In Myanmar’s Kachin State, a women’s drop-in centre has transformed into more than just a harm reduction facility. Leading up to International Women’s Day, we spoke with Thinzar Tun (AHRN Myanmar) about what makes this centre special.
The recent publication of two single pieces of legislation - the amended 1993 Narcotic Drugs and Psychotropic Substances Law and the first National Drug Control Policy - is likely to form the basis of Myanmar’s drug policy for several years to come. What does it mean for the country’s transition towards an evidence-based approach to drug control, and how can the gaps between the two documents be addressed?
John Walsh, Ann Fordham, Martin Jelsma, Hannah Hetzer
22 September 2018
The "Global Call to Action" document that the U.S. government is circulating—and heavily pressuring reluctant countries to sign—is explicitly “not open for negotiation.” Far from an effort at achieving mutual understanding and genuine consensus, it is an instance of heavy-handed U.S. “with us or against us” diplomacy.
David Bewley-Taylor, Tom Blickman, Martin Jelsma, John Walsh
03 April 2018
Ever since the introduction of Bill C-45, questions have been swirling concerning Canada’s position relative to the UN drug control conventions: conventions to which Canada is a party and that, crucially, prohibit the creation of regulated markets for the recreational use of cannabis.
Multistakeholder approaches are becoming ever more dominant, shaping standards for products, setting the rules for global initiatives and increasingly entering every arena of global governance including the UN. What is the driving force behind these initiatives? To whom are they accountable? What are the implications for social movements seeking to challenge unjust power relations within states and globally?
The recent report ‘The Netherlands and Synthetic Drugs: An Inconvenient Truth’ argues for increasing resources to expand anti-drug efforts in the Netherlands. In a topical opinion piece, Tom Blickman addresses the crucial issues at hand.
How can we resolve the tensions between current drug control policies and states’ human rights obligations? The international human rights framework clearly establishes that, in the event of conflicts between obligations under the UN Charter and other international agreements, human rights obligations take precedence. As legally regulated cannabis markets start to grow, now is the time to secure a legitimate place for small farmers using alternative development, human rights and fair trade principles.
TNI's Prof. Dave Bewley-Taylor recently delivered a statement on how states can reconcile treaty obligations with democratically mandated policy shifts at the national level to a legally regulated cannabis market, with due regard for international law, and what role the International Narcotics Control Board can play in this process.
From 16 to 18 October 2019, representatives of member states, intergovernmental organisations, and civil society attended the 6th Intersessional Meeting of the Commission on Narcotic Drugs. On 17 October 2019, representatives of coca and opium growers from Colombia and Myanmar delivered statements highlighting the situation of communities involved in the illicit cultivation of coca and opium in both countries. Below are their full statements.
Tom Blickman, Katie Sandwell, Dania Putri, Xabier Arana, Tom Decorte, Vibeke Asmussen Frank, Dirk J. Korf, Ingo Ilja Michels, Maj Nygaard-Christensen, Tim Pfeiffer-Gerschel, Heino Stöver, Bernd Werse, Frank Zobel
20 March 2019
In order to better understand the situation around, and possibilities for, local and regional cannabis regulation, a series of six country reports were developed. The country reports provide detailed information about the state of cannabis policy, and the possibilities for change, within each country. This Report summarises some of the key findings from the research and explores opportunities, obstacles, and strategies for cannabis regulation at the municipal and regional level.
John Walsh, Martin Jelsma, Tom Blickman, David Bewley-Taylor
19 March 2019
The World Health Organization’s (WHO) Expert Committee on Drug Dependence (ECDD or Expert Committee) released in January 2019 the outcomes of the first-ever critical review of cannabis, recommending a series of changes in the current scheduling of cannabis-related substances under the UN drug control conventions.
What are drugs and why are they controlled? What are the benefits and harms of taking drugs? How public health policies can address drug use? Learn the answers to these questions and more in the free online course 'Drugs, drug use, drug policy and health'.
The recently-released “Myanmar Opium Survey 2018” by the United Nations Office on Drugs and Crime (UNODC) entails specific accusations against several of the conflict actors. This commentary explains how this further distorts, rather than reflects, the complex realities in Myanmar.
This March, our video advocacy team attended the 58th session of the Commission on Narcotic Drugs, the largest drug policy gathering in the world, to find out how governments and NGOs feel about the prospects of drug policy reform. We produced a series of short thematic videos, to give you an overview of the current state of political debate on the burning issues of international drug control.
Over the past decade, methamphetamine use has grown more popular in Myanmar, Thailand and Southern China. Based on in-depth interviews conducted with individuals who use methamphetamine, this briefing sheds light on the importance of promoting an environment that reinforces, rather than undermines, the ability of people who use methamphetamine to regulate their drug use, preserve their health and adopt safer practices.
This IDPC Briefing reviews the data in the latest report from the UN Office on Drugs and Crime on the state of the global market, criticises the claims made in the report that international action is successfully controlling the market, and questions the political objectivity of the UNODC as we approach the review of the global objectives set in 1998.